NCT02179658View on ClinicalTrials.gov

A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

September 8, 2016

Study Completion Date

September 8, 2016

Conditions
Clostridium Difficile
Interventions
DRUG

OPT-80

oral

DRUG

vancomycin

oral

Trial Locations (7)

Unknown

Chugoku

Chūbu

Hokkaido

Kanto

Kinnki

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT02179658 - A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) | Biotech Hunter | Biotech Hunter